Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 39,156 shares at $29.43 ($1.2M) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market sale of $1.2M CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.43 | 19,578 | $576K | 50.0% |
| 2 | $29.43 | 19,578 | $576K | 50.0% |
| Total | $29.43 avg | 39,156 | $1.2M | 100% |
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |